A61P 13 - Drugs for disorders of the urinary system

Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
11/2011
11/23/2011	CN102247387A Norfloxacin phenazopyridine tablets and preparation process method and use thereof
11/23/2011	CN102247379A Compound preparation and preparation method thereof
11/23/2011	CN102000157B Medicinal liquor with treatment and health-care functions
11/23/2011	CN101884734B Chinese medicinal composition for treating dribbling urination
11/23/2011	CN101843706B Chinese medicament for treating chronic kidney failure
11/23/2011	CN101757527B Traditional Chinese medicine composition for treating nephritis and preparation method thereof
11/23/2011	CN101703733B Medicament for treating tumor-like diseases
11/23/2011	CN101703617B Medicinal composition for treating diabetic nephropathy and preparation method thereof
11/23/2011	CN101675950B A traditional Chinese medicine preparation for treating diabetic nephropathy, and preparation method and application thereof
11/23/2011	CN101596170B Trospium chloride slow-release tablet
11/23/2011	CN101579410B Medicinal composition for treating prostatauxe
11/23/2011	CN101573120B Use of 10-[(3r)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10h-phenothiazine for the preparation of a drug having a selective inhibition of muscarinic m1, m2 and m3 receptors
11/23/2011	CN101336230B Pharmaceutical for use in the treatment of ureterolithiasis
11/22/2011	US8063242 2-aryl-propionic acids and pharmaceutical compositions containing them
11/22/2011	US8063087 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazole-2-ones and, 4-(substituted cycloalkylmethyl) imidazole-2-ones and related compounds
11/22/2011	US8063045 Fluoropyrrolidines having dipeptidyl peptidase enzyme inhibitory activity
11/22/2011	CA2524023C Use of phenoxyacetic acid derivatives for treating hyperactive bladder
11/22/2011	CA2489902C Thiazole derivatives as phosphodiesterase iv inhibitors
11/22/2011	CA2484395C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
11/22/2011	CA2480452C Thioxanthine derivatives as myeloperoxidase inhibitors
11/22/2011	CA2455392C Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same
11/22/2011	CA2352324C Derivatives of (-)-venlafaxine and methods of preparing and using the same
11/17/2011	WO2011143475A1 Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use
11/17/2011	WO2011141787A1 Use of interferon alpha for the treatment of chronic kidney disease
11/17/2011	US20110281952 Deuterium-enriched tolterodine
11/17/2011	US20110281913 Melanocortin receptor antagonist compounds, process for preparing them and use thereof in human medicine and cosmetics
11/17/2011	US20110281885 Therapeutic agents useful for treating pain
11/17/2011	US20110281884 Fused derivatives as pi3kdelta inhibitors
11/17/2011	US20110281878 INHIBITORS OF p38
11/17/2011	US20110281870 Novel substituted octahydrocyclopenta[c]pyrrol-4-amines as calcium channel blockers
11/17/2011	US20110281865 Novel 3,5-disubstituted-3h-imidazo[4,5-b]pyridine and 3,5- disubstituted -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of protein kinases
11/17/2011	US20110281854 Morpholine compounds
11/17/2011	US20110281846 Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
11/17/2011	US20110281844 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications
11/17/2011	US20110281840 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
11/17/2011	US20110281826 Stilbene derivatives for adp-ribosyl cyclase inhibitors
11/17/2011	US20110281801 Prediction and prevention of preeclampsia
11/17/2011	US20110281732 Crosslinked Polyvinylpyrrolidone Compositions
11/17/2011	US20110280956 Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use
11/17/2011	US20110280851 Compositions Comprising Cranberry Extract and Methods of Use Thereof
11/17/2011	US20110280830 Albumin Fusion Proteins
11/17/2011	DE102010022174A1 Neue Darreichungsformen für Cineol New forms of cineole
11/16/2011	EP2386859A2 Diagnostic tumor markers
11/16/2011	EP2386566A2 Chi-conotoxin peptides (II)
11/16/2011	EP2386546A1 Novel pyrazole-3-carboxamide derivate having 5-ht2b receptor antagonist activity
11/16/2011	EP2386545A1 Heteroaryl ureas containing nitrogen hetero-atoms as P38 kinase inhibitors
11/16/2011	EP1506166B1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/16/2011	EP1487458B1 Multi-substituted selective androgen receptor modulators and methods of use thereof
11/16/2011	CN1931228B Lysimachia herb total flavone extract and its preparation process
11/16/2011	CN102245586A Thiadiazole-substituted arylamides
11/16/2011	CN102245584A Antagonists of lysophosphatidic acid receptors
11/16/2011	CN102245181A Heterocyclic benzimidazoles as TRPM8 modulators
11/16/2011	CN102242154A Liquid fermentation method for producing paecilomyces cicadae mycelia and application of culture product
11/16/2011	CN102242079A Medium for producing Paecilomyces cicadae spore, culture method thereof, culture product thereof and application thereof
11/16/2011	CN102242070A Method for artificially culturing paecilomyces cicadae and application of culturing product thereof
11/16/2011	CN102242069A Paecilomycescicadae (Miq.)Samson and application thereof
11/16/2011	CN102242043A Bo beer blending liquor and preparation method thereof
11/16/2011	CN102241680A Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
11/16/2011	CN102241621A 5,5-disubstituted-2-iminopyrrolidine derivatives, preparation method thereof, and medical applications thereof
11/16/2011	CN102240388A Ginger extract and preparation method and applications thereof
11/16/2011	CN102240373A Medicine for treating Cystitis
11/16/2011	CN102240370A Chinese medicinal composition for treating benign prostatic hyperplasia and preparation method thereof
11/16/2011	CN102240331A Ointment mainly for treating rheumatoid arthritis
11/16/2011	CN102240327A Method for extracting total anthraquinone in rhubarb from traditional Chinese medicine rhubarb by supercritical fluid
11/16/2011	CN102240320A Motherwort and astragalus capsule used for treating prostatic hyperplasia
11/16/2011	CN102240314A Medicine for treating urinary tract infection
11/16/2011	CN102240301A Single-composition traditional Chinese medicine preparation, and preparation method and application thereof
11/16/2011	CN102240285A Amoxicillin and potassium clavulanate tablet for dogs and cats, and its preparation method and application
11/16/2011	CN102240272A Potassium citrate sustained release tablet and preparation method thereof
11/16/2011	CN102240264A Application of poly(cinnamic alcohol) injection used as cyst treatment medicament
11/16/2011	CN102018903B Pure traditional Chinese medicine preparation for treating glomerular diseases and preparation method thereof
11/16/2011	CN101914536B Locked nucleic acid ribozyme of targeted serine-threonine protein kinase aurora kinase A and application thereof
11/16/2011	CN101810757B Plaster for treating benign prostatic hyperplasia
11/16/2011	CN101756906B Pharmaceutical composition of cefcapene pivoxil hydrochloride granules and preparation method thereof
11/16/2011	CN101590213B Chinese medicinal decoction for treating lithiasis
11/16/2011	CN101549087B Compound golden gardenia capsule
11/16/2011	CN101461859B Method for controlling quality of anti-inflammation antibacterial medicament
11/16/2011	CN101411833B Dragon's blood extract as well as preparation method and application thereof
11/16/2011	CN101357144B Selaginella uncinata extraction, its preparation method and application
11/15/2011	US8058314 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
11/15/2011	US8058282 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy
11/15/2011	US8058280 Substituted thieno[2,3-d]pyrimidin-2,4-dione compounds and uses thereof
11/15/2011	CA2479126C Combination treatments for chemokine-mediated diseases
11/15/2011	CA2257851C Modulators of tissue regeneration
11/10/2011	WO2011139295A1 Small molecule inhibitors of protein kinases
11/10/2011	WO2011138916A1 Polycyclic compound
11/10/2011	WO2011085009A3 Polymorphic, crystalline and mesophase forms of sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetate, and uses thereof
11/10/2011	US20110275708 Polycyclic compounds and methods related thereto
11/10/2011	US20110275701 Anti-thrombin aptamer formulations and methods for use
11/10/2011	US20110275699 Treatment For Obesity And Diabetes
11/10/2011	US20110275680 Noxel oxime derivatives of 3, 5-seco-4-nor-cholestane, pharmaceutical compositions containing same, and method for preparing same
11/10/2011	US20110275679 Flupirtine hydrochloride maleic acid cocrystal
11/10/2011	US20110275671 Dihydroindolinone derivatives
11/10/2011	US20110275669 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
11/10/2011	US20110275640 Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound
11/10/2011	US20110275634 Dual-acting pyrazole antihypertensive agents
11/10/2011	US20110275627 Indolizine inhibitors of leukotriene production
11/10/2011	US20110275615 Novel substituted amides, their preparation and use
11/10/2011	US20110275607 Nuclear transport modulators and uses thereof
11/10/2011	US20110275578 Treatment of nephrolithiasis and urolithiasis using 1,2,3,4,6-penta-o-galloyl-beta-d-glucose (pgg)

1 ... 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 ... 562